Viewing StudyNCT00192062



Ignite Creation Date: 2024-05-05 @ 11:58 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192062
Status: COMPLETED
Last Update Posted: 2007-08-31
First Post: 2005-09-12

Brief Title: A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer
Sponsor:
Organization: Eli Lilly and Company